From August 1, 2023 to October 31, 2023, the company has repurchased 5,300 shares, representing 0.04% for $0.03 million. With this, the company has completed the repurchase of 120,300 shares, representing 0.89% for $0.71 million under the buyback announced on April 5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | -1.42% | -4.34% | -13.70% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
1st Jan change | Capi. | |
---|---|---|
-13.70% | 65.93M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.